BTAX OTC
Biostax Corp.
1W: +0.0%
1M: +100.0%
3M: +100.0%
YTD: +100.0%
1Y: +100.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$1M
-27.6% ▼
Net Income
-$2M
+33.2% ▲
EPS (Diluted)
$-0.03
+70.0% ▲
EBITDA
-$2M
+37.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — |
| R&D Expenses | $126K | $153K | $14K | $474K |
| SG&A Expenses | $760K | $586K | $1M | $957K |
| Operating Expenses | $887K | $738K | $1M | $1M |
| Operating Income | -$887K | -$738K | -$1M | -$1M |
| Operating Margin | — | — | — | — |
| Interest Expense | $653K | $211K | $120K | $168K |
| Income Before Tax | $2M | $4M | -$4M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2M | $4M | -$4M | -$2M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $0.11 | $0.38 | $-0.10 | $-0.03 |
| EBITDA | $2M | $4M | -$3M | -$2M |
| Shares Outstanding | 461190 | 9M | 36M | 84M |